Form D — Solaris Endovascular Inc.
0002156481-26-000001 · filed Oct 1, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $10,000,000
- Total sold
- $4,972,500
- Minimum investment
- $2,500
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Solaris Endovascular Inc.
- CIK
- 2156481
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 3232 MCKINNEY AVENUE
DALLAS, TX 75204 - Phone
- 215-688-6196
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Randolph W. Hubbell · Executive OfficerDallas, TX Find on LinkedIn ↗
-
Alexander Marra Moreira · DirectorDallas, TX Find on LinkedIn ↗
-
Melchiades de Cunha Neto · DirectorDallas, TX Find on LinkedIn ↗
-
Marco Costa · DirectorDallas, TX Find on LinkedIn ↗
-
David Stack · DirectorDallas, TX Find on LinkedIn ↗
-
Matthew Head · Executive OfficerDallas, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗